Navigation Links
Chemo May Raise Risk of Falls in Breast Cancer Survivors
Date:3/4/2011

FRIDAY, March 4 (HealthDay News) -- Breast cancer survivors may be at increased risk for falls and broken bones due to the combined effects of chemotherapy and endocrine therapy, a new study suggests.

Researchers looked at 59 postmenopausal breast cancer survivors, and found that 58 percent of them had experienced a fall in the year before the start of the study and 47 percent had a fall during the six-month study period.

Those rates are much higher than the 25 percent to 30 percent annual fall rate reported for community-dwelling adults over 65 years old, noted Kerri M. Winters-Stone, an associate professor and associate scientist at Oregon Health & Science University (OHSU) School of Nursing, and colleagues.

Balance was the only difference between breast cancer survivors who fell and those who did not. The researchers said their findings also suggest that balance problems may be due to chemotherapy-related changes in the vestibular system, which is involved in balance and spatial orientation.

The study is scheduled for publication in the April issue of the Archives of Physical Medicine and Rehabilitation.

"Falls in breast cancer survivors are understudied and deserve more attention, particularly in light of the increase in fractures after breast cancer treatment and the relationship of falls to fractures," Winters-Stone, who is also a member of the OHSU Knight Cancer Institute in Portland, said in a journal news release.

"Our findings add to growing evidence that fall risk is increased in breast cancer survivors and that vestibular function may underpin associations between breast cancer treatment and falls," she added.

More information

Learn more about balance from the Vestibular Disorders Association.

-- Robert Preidt

SOURCE: Archives of Physical Medicine and Rehabilitation, news release, March 4, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New developments in nanotechnology tackle the 2 biggest problems associated with chemotherapy
2. Roche/Genentech/Chugais Herceptin as an Add-On to Standard Chemotherapy Will Become Decision Resources Clinical Gold Standard in 2013 for the Treatment Of Gastric Cancer
3. Scientists identify microRNA as possible cause of chemotherapy resistance
4. Study evaluates costs and benefits of new chemotherapy drugs
5. Older Colon Cancer Patients Less Likely to Get Chemo
6. Are New Chemo Treatments Cost-Effective?
7. BioSphere Medical's HepaSphere Microspheres Safely Deliver Doxorubicin in Liver Cancer Chemoembolization Therapy -- Study Presented at SIR
8. Researchers find new chemotherapy combination shows promise in endometrial cancer
9. Chemotherapy plus synthetic compound provides potent anti-tumor effect in pancreatic cancers
10. Recommended Dental Care for Chemotherapy Patients -- Advice from Steven McConnell, DDS
11. Chemo May Boost Survival After Lung Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemo May Raise Risk of Falls in Breast Cancer Survivors
(Date:4/22/2017)... ... April 22, 2017 , ... ... as Vice President of Sales and Business Development at OAKWORKS, Inc. Mr. ... engagements, business development, and strategic planning for the company. Recognized industry-wide as ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... An April ... of a pair of ancient teeth, which reveal a great deal about prehistoric ice-age ... a sharp stone may have been used to remove decayed dental matter, and that ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to ... in the 2017 London Marathon. Set to take place on April 23rd, the London Marathon ... Dr. Schwartz will run as part of team EMPOWER, raising money for the international charity, ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Chicago plastic surgeon, ... removal of osteoma. An osteoma is a benign bony lump located on the forehead ... and can cause difficulties with sight and pain. Dr. Shah has discovered an approach ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... ZappRx, Inc ., a digital health company focused on modernizing ... closed $25 million in Series B funding led by Qiming ... Seattle that is part of a broader ... round included participation from SR One , who led ... (formerly Google Ventures). As part of the financing, Mark ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
Breaking Medicine Technology: